Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xan Confections was a specialty chocolatier focused on producing health-conscious gourmet treats, specifically targeting consumers with dietary restrictions such as diabetes and celiac disease. The company utilized a proprietary non-dairy, low-glycemic cocoa butter substitute and natural sweeteners like agave nectar to create chocolates that were vegan, gluten-free, and low in calories. Their product lines, including the Saintly Sins and Big Shot series, were designed to provide a high-quality culinary experience without the health drawbacks of traditional high-sugar confections. While primarily a consumer goods company, Xan Confections operated at the intersection of food science and health by addressing specific metabolic and dietary health needs through innovative ingredient formulation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xan Confections.